Laboratory of Immunoparasitology of Neglected Diseases and Cancer, Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, 86057-970, Londrina, Paraná, Brazil.
Laboratory of Immunoparasitology of Neglected Diseases and Cancer, Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, 86057-970, Londrina, Paraná, Brazil; Gonçalo Moniz Institute (FIOCRUZ/Bahia), 40296-710, Salvador, Bahia, Brazil.
Chem Biol Interact. 2022 Jan 5;351:109713. doi: 10.1016/j.cbi.2021.109713. Epub 2021 Oct 23.
Leishmaniasis is an infectious-parasitic disease caused by the protozoan Leishmania spp. The available treatments are based upon expensive drugs bearing adverse side-effects. The search for new therapeutic alternatives that present a more effective action without causing adverse effects to the patient is therefore important. The objective of this study was to evaluate the in vitro effect of botryosphaeran, a (1 → 3)(1 → 6)-β-D-glucan, on the promastigote and intracellular amastigote forms of Leishmania amazonensis. The direct activity of botryosphaeran on promastigote forms was evaluated in vitro and inhibited proliferation, the IC 7 μg/mL in 48 h was calculated. After 48 h treatment, botryosphaeran induced nitric oxide production (NO), caused mitochondrial membrane hyperpolarization, increased reactive oxygen species (ROS), and accumulation of lipid vesicles in promastigotes, resulting in apoptosis, necrosis and autophagy, and was accompanied by morphological and ultrastructural changes. The range of concentrations used did not alter the viability of peritoneal macrophages from BALB/c mice and erythrocytes of sheep. Botryosphaeran was able to reduce the number of infected macrophages and the number of amastigotes per macrophage at 12.5 μg/mL (50.75% ± 6.48), 25 μg/mL (55.66% ± 3.93) and 50 μg/mL (72.9% ± 6.98), and IC 9.3 μg/mL (±0.66) for intracellular amastigotes forms. The leishmanicidal effect was due to activation of NF-κB and promoted an increase in pro-inflammatory cytokines (TNF-α and IL-6), iNOS and microbial-derived ROS and NO, in addition to decreasing the levels of SOD. Based upon the data obtained, we infer that botryosphaeran exerted an active leishmanicidal and immunomodulatory effect, acting on promastigotes through autophagic, apoptotic and necrosis processes, and in the intracellular amastigote form, through the action of ROS and NO.
利什曼病是一种由原生动物利什曼原虫引起的感染性寄生虫病。现有的治疗方法基于昂贵的药物,这些药物具有不良的副作用。因此,寻找新的治疗方法非常重要,这些方法应该具有更有效的作用,而不会对患者造成不良反应。本研究的目的是评估博落回烷醇,一种(1→3)(1→6)-β-D-葡聚糖,对亚马逊利什曼原虫前鞭毛体和细胞内无鞭毛体形式的体外作用。博落回烷醇对前鞭毛体的直接活性在体外进行评估,并抑制增殖,在 48 小时内计算出 IC 7μg/mL。在 48 小时治疗后,博落回烷醇诱导一氧化氮(NO)的产生,引起线粒体膜超极化,增加活性氧(ROS)并在前鞭毛体中积累脂质囊泡,导致细胞凋亡、坏死和自噬,并伴有形态和超微结构的变化。使用的浓度范围不会改变 BALB/c 小鼠腹腔巨噬细胞和绵羊红细胞的活力。博落回烷醇能够减少感染的巨噬细胞数量和每个巨噬细胞中的无鞭毛体数量,在 12.5μg/mL(50.75%±6.48)、25μg/mL(55.66%±3.93)和 50μg/mL(72.9%±6.98),以及对细胞内无鞭毛体形式的 IC 9.3μg/mL(±0.66)。杀利什曼原虫作用是由于 NF-κB 的激活,并促进促炎细胞因子(TNF-α和 IL-6)、iNOS 和微生物衍生的 ROS 和 NO 的增加,同时降低 SOD 水平。根据获得的数据,我们推断博落回烷醇发挥了积极的杀利什曼原虫和免疫调节作用,通过自噬、凋亡和坏死过程作用于前鞭毛体,在细胞内无鞭毛体形式中,通过 ROS 和 NO 的作用。